Despite recent technological advancements and promising preclinical experiments, brain
tumor patients are still met with limited treatment options. Some of the barriers to clinical …

Treatment of brain tumors is challenging since the blood–brain tumor barrier prevents
chemotherapy drugs from reaching the tumor site in sufficient concentrations …

Introduction: The blood-brain barrier (BBB) selectively impedes the transportation of drug
molecules into the brain, which makes the drug delivery and targeting of brain tumors very …

Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …

The blood–brain barrier (BBB) maintains the integrity and homeostasis of the central
nervous system (CNS) yet represents an intimidating hurdle for efficient drug delivery to …

Gliomas constitute about 80% of brain tumors and have a meager two-year survival rate.
The treatment options available are very few because of poor prognosis and a lack of …

The blood–brain barrier (BBB) is a stealth barrier that protects the brain, and allows the entry
of only a select pool of compounds into the brain and functions towards the maintenance of …

Brain cancer is the most aggressive one among various cancers. It has a drastic impact on
people's lives because of the failure in treatment efficacy of the currently employed …

Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors addresses brain
anatomy and tumors and the progress and challenges in delivering drugs across the blood …

Malignant brain tumor, including the most common type glioblastoma, are histologically
heterogeneous and invasive tumors known as the most devastating neoplasms with high …